Prof. Dr. med. Oliver Schnell

Lehrstuhl für Neurochirurgie

Multiomic spatial landscape of innate immune cells at human central nervous system borders (2023) Sankowski R, Süß P, Benkendorff A, Böttcher C, Fernandez-Zapata C, Chhatbar C, Cahueau J, et al. Journal article Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial (2023) Weller J, Schäfer N, Schaub C, Tzaridis T, Zeyen T, Schneider M, Potthoff AL, et al. Journal article Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up (2023) Pertz M, Schlömer S, Seidel C, Hentschel B, Löffler M, Schackert G, Krex D, et al. Journal article Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial (2022) Zeyen T, Potthoff AL, Nemeth R, Heiland DH, Burger MC, Steinbach JP, Hau P, et al. Journal article T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10 (2022) Ravi VM, Neidert N, Will P, Joseph K, Maier JP, Kückelhaus J, Vollmer L, et al. Journal article AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas (2022) Bunse L, Rupp AK, Poschke I, Bunse T, Lindner K, Wick A, Blobner J, et al. Journal article New strategies to improve clinical outcomes for diabetic kidney disease (2022) Forst T, Mathieu C, Giorgino F, Wheeler DC, Papanas N, Schmieder R, Halabi A, et al. Journal article, Review article LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT (2022) Weller J, Zeyen T, Schlegel U, Lazaridis L, Werner JM, Onken J, Zeiner P, et al. Conference contribution Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics (2022) Koessinger AL, Cloix C, Koessinger D, Heiland DH, Bock FJ, Strathdee K, Kinch K, et al. Journal article Surgical Treatment of Glioblastoma: State-of-the-Art and Future Trends (2022) Sales AH, Beck J, Schnell O, Fung C, Meyer B, Gempt J Journal article, Review article